98 algorithm-development-"Multiple"-"Simons-Foundation"-"Prof"-"UNIS"-"St" Fellowship positions at Nature Careers
Sort by
Refine Your Search
-
Listed
-
Country
-
Field
-
The BrainSignatures Lab (BSL) in its current form is a proteomics lab dedicated to finding biofluid signatures of Alzheimer's disease and other dementias. We follow multiple longitudinal cohorts
-
the following things we are working on this may be the perfect opportunity: 1. Development of cell-free DNA (mutation and methylation), RNA, and exosomal-based liquid assays for early cancer detection
-
partners. Main Duties Improve, develop, implement, and apply advanced computational tools and workflows to process, analyse, and interpret large-scale LCMS-based metabolomics datasets across multiple species
-
autoimmunity. The overarching goal of the Wu lab is to harness innate immunity to develop new immunotherapies for cancer and inflammatory diseases. Our recent research has been published in top-tier journals
-
approaches and biochemical assays to target key proteins. This funded position is for a postdoctoral trainee interested in aiding the development of novel therapeutics for treating cancer or metabolic disease
-
to intervene the malignancies 3) collaborative analyses of myeloid cancers genomics using high-throughput single-cell sequencing chor high throughput proteomics 4) development of small molecule drugs and PROTAC
-
visit here . As a successful candidate you will: · Focus on metabolic regulations of cardiovascular disease under cancer treatment and metabolic syndrome · Utilize multiple cutting-edge
-
characters in Japanese. Include the research concept you wish to pursue.) If there is another main laboratory you wish to belong to, indicate that name and prepare a statement of reasons separately. Please
-
Southwestern (UTSW) Medical Center in Dallas, seeks applications for multiple postdoctoral fellow positions to investigate memory mechanisms in the mammalian brain using innovative molecular, cellular
-
developing drugs for the treatment of cancer, vascular anomalies, macular degeneration and glaucoma. The group is dedicated to identifying novel targets, pursuing high throughput screening of therapeutics and